211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
Conditions
Acute Lymphoblastic Leukemia in Remission · Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome · Acute Myeloid Leukemia in Remission · Chronic Myelomonocytic Leukemia · Myelodysplastic Syndrome With Excess Blasts · Recurrent Acute Lymphoblastic Leukemia · Recurrent Acute Myeloid Leukemia · Refractory Acute Lymphoblastic Leukemia · Refractory Acute Myeloid Leukemia · Recurrent Mixed Phenotype Acute Leukemia · Refractory Mixed Phenotype Acute Leukemia · Hematopoietic and Lymphoid Cell Neoplasm
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Contact: Principal Investigator (Phuong Vo)
Study leads
Phuong Vo
Principal Investigator
Fred Hutchinson Cancer Center